...
首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013
【24h】

Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013

机译:日本初级保健医院生产碳碱酶机肠杆菌植物的分子流行病学,2010-2013

获取原文
获取原文并翻译 | 示例
           

摘要

Recently, carbapenemase-producing Enterobacteriaceae (CPE) have been spreading worldwide and have become a threat in healthcare systems. We investigated the isolation frequency and molecular epidemiological characteristics of CPE isolated from clinical samples collected at a primary care hospital over the four years of 2010-2013 in Japan. CPE were detected in 17 (0.34%) of 4875 isolates by the broth microdilution method, sodium mercaptoacetate inhibition test, and modified Hodge test using meropenem disks. The frequency of CPE isolates was 0.09% in 2010, 0.17% in 2011, 0.16% in 2012 and 0.82% in 2013. Isolates positive for carbapenemase included Klebsiella pneumoniae (0.92%), Escherichia coli (0.12%), Enterobacter cloacae (0.80%), Klebsiella oxytoca (0.55%), Enterobacter aerogenes (0.81%) and Proteus mirabilis (0.08%). Antimicrobial susceptibility testing showed low MICs for piperacillin-tazobactam, amikacin, ciprofloxacin and levofloxacin, and only one multidrug-resistant strain. The carbapenemase genotype of all strains was IMP-6, and 94% of the strains were simultaneous CTX-M-2 producers. Two K. pneumoniae and 3 E. coli isolates showed the same pulsed-field gel electrophoresis group. Multilocus sequence typing detected no international high-risk clone types. Plasmid replicon typing detected IncN from all CPE strains, and IncF and IncFIB were simultaneously detected in 24% and 18%, respectively. All patients with detected CPE were inpatients, and many were elderly long-term hospitalized patients or had a history of prior vancomycin or levofloxacin antibiotic administration. The rapid spread of CPE is a concern in Japan. Preventive measures must be implemented against the spread of CPE after considering the epidemiological trend of CPE detection, antibiograms, and risk factors. (C) 2017 Published by Elsevier Ltd on behalf of Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
机译:最近,产生的碳碱酶活性的肠杆菌(CPE)一直在全世界传播,并已成为医疗系统的威胁。我们研究了在2010-2013在日本四年的初级保健医院收集的CPE分离的CPE分离频率和分子流行病学特征。通过肉汤微量稀释方法,巯基醋酸钠抑制试验和改进的Hodge试验,在17(0.34%)4875分离物中检测到CPE。 CPE分离株的频率在2010年为0.09%,2011年0.17%,2012年0.16%,2013年0.16%。分离碱蛋白酶阳性阳离子(0.92%),大肠杆菌(0.12%),肠杆菌(0.0%) ),Klebsiella oxytoca(0.55%),肠杆菌空气(0.81%)和蛋白质mirabilis(0.08%)。抗微生物易感性测试显示哌啶蛋白 - 塔扎酰胺,Amikacin,Ciprofloxacin和左氧氟沙星的低麦克风,并且只有一种多药抗性菌株。所有菌株的碳癌基因型是IMP-6,94%的菌株是同时CTX-M-2生产商。两种K.肺炎和3e.coli分离物显示出相同的脉冲场凝胶电泳组。多层序列打字检测到无国际高风险克隆类型。从所有CPE菌株和Incf和Incfib分别分别以24%和18%同时检测到从所有CPE菌株和Incf和Incfib的质粒复制子。所有检测到的CPE患者都是住院患者,许多人都是老年长期住院患者或患有先前万古霉素或左氧化鲸抗生素给药的历史。 CPE的迅速传播是日本问题。在考虑CPE检测,抗动术和危险因素的流行病学趋势之后,必须根据CPE的传播实施预防措施。 (c)2017年由elsevier有限公司发布代表日本化疗和日本传染病协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号